Jump to content

Mesothelioma Treatment Costs Quick Reference

From WikiMesothelioma — Mesothelioma Knowledge Base

Mesothelioma Treatment Costs Quick Reference

Overview

Mesothelioma treatment is among the most expensive of any cancer diagnosis, with total lifetime costs frequently exceeding $400,000 and reaching $1 million or more.[1] The mean cost per mesothelioma hospitalization is $24,901 based on national hospital discharge data, and patients typically require multiple hospitalizations over the course of treatment.[1] Since the 2020 FDA approval of immunotherapy (Opdivo + Yervoy) as a first-line treatment, average per-patient costs have increased substantially, with the immunotherapy treatment course alone totaling $292,319.[2] Multiple financial assistance programs — including $30+ billion in asbestos trust funds — can help offset these expenses.[3]

Key Facts

Category Detail
Total Lifetime Cost $400,000–$1,000,000+[1][4]
Mean Hospitalization Cost $24,901 per episode (2014)[1]
Most Expensive Standard Treatment Immunotherapy: $292,319 total course[2]
Most Expensive Surgery EPP: $62,408 per procedure[1]
Standard Chemotherapy (6 cycles) $38,779–$87,741[1]
Radiation Per Course $7,500–$11,100 median[5]
Bankruptcy Risk Cancer patients 2.65× more likely to file[6]
Medicare Part D OOP Cap $2,000/year (Inflation Reduction Act, 2025)[7]
Trust Fund Assets Available $30+ billion across 60+ trusts[3]
Clinical Trial Participation Less than 5% of mesothelioma patients[8]

Treatment Cost Comparison

Treatment Cost Measurement
EPP Surgery $62,408 Per procedure[1]
P/D Surgery $53,993 Per procedure[1]
CRS/HIPEC $38,369 Average hospital cost[9]
Pemetrexed + Cisplatin $38,779 6 cycles drug cost[1]
Pemetrexed + Cisplatin + Bevacizumab $87,741 6 cycles drug cost[1]
Opdivo + Yervoy $292,319 Total treatment course[2]
Radiation Therapy $9,000 Median per course[5]
CAR-T Cell Therapy $300,000–$475,000 Per infusion (experimental)[10]
TTFields (Optune Lua) ~$21,000 Per month[11]

Frequently Asked Questions

How much does mesothelioma treatment cost?

Total lifetime costs typically range from $400,000 to over $1 million, depending on treatment approach. The mean cost per hospitalization is $24,901, with surgical cases averaging $29,344.[1] Immunotherapy with Opdivo plus Yervoy totals $292,319 over the treatment course.[2]

Does insurance cover mesothelioma treatment?

Most health insurance plans cover standard mesothelioma treatments, though patients face deductibles averaging $1,787 for employer plans.[12] Medicare covers hospice care with no deductible and caps Part D prescription costs at $2,000 per year under the Inflation Reduction Act.[7][13]

What financial help is available for mesothelioma patients?

Patients may access asbestos trust funds ($100,000–$400,000+ combined), personal injury lawsuits, VA disability benefits, SSDI through Compassionate Allowances, and manufacturer assistance programs.[14][3]

Do treatment costs vary by location?

Yes. Northeast U.S. hospitalizations average $33,396, compared to $18,206 in the Midwest — a difference of 83%.[1] U.S. treatment costs are also substantially higher than in most other developed nations.[1]

Can clinical trials reduce treatment costs?

Clinical trial sponsors typically cover investigational drug costs, and insurance must cover routine care under the ACA. However, less than 5% of mesothelioma patients currently participate in clinical trials.[8][15]

Quick Statistics

  • Total lifetime mesothelioma treatment costs range from $400,000 to $1,000,000+[1][4]
  • Mean hospitalization cost is $24,901 based on 1,675 hospital discharges nationally[1]
  • Immunotherapy (Opdivo + Yervoy) costs $292,319 over the full treatment course[2]
  • Cancer patients are 2.65 times more likely to file for bankruptcy than non-cancer patients[6]
  • Northeast hospital costs are 83% higher than Midwest costs for mesothelioma[1]
  • More than $30 billion remains in asbestos trust funds for mesothelioma patients[3]
  • 35% of cancer caregivers report stopping work due to caregiving demands[16]
  • Less than 5% of mesothelioma patients participate in clinical trials[8]
  • Medicare Part D caps prescription out-of-pocket costs at $2,000/year under the Inflation Reduction Act[7]

Get Help

Resource Description
Danziger & De Llano(866) 222-9990 Free consultation on mesothelioma compensation and trust fund claims
Mesothelioma Lawyers Near Me Find experienced mesothelioma attorneys and take a free case evaluation quiz
Mesothelioma.net Patient resources, treatment information, and financial assistance guides

References

  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 Borrelli EP, McGladrigan CG, et al. "Costs of medical care for mesothelioma." Rare Tumors. 2019;11:2036361319863498. https://pmc.ncbi.nlm.nih.gov/articles/PMC6637828/
  2. 2.0 2.1 2.2 2.3 2.4 Gao L, Wang J, et al. "Cost-effectiveness of nivolumab plus ipilimumab as first-line therapy for unresectable malignant pleural mesothelioma." Front Public Health. 2022;10:947221. https://pmc.ncbi.nlm.nih.gov/articles/PMC9354521/
  3. 3.0 3.1 3.2 3.3 U.S. Government Accountability Office. "Asbestos Injury Compensation: The Role and Administration of Asbestos Trusts." GAO-11-819, September 2011. https://www.gao.gov/products/gao-11-819
  4. 4.0 4.1 Mesothelioma Treatment Costs, Mesothelioma Lawyer Center.
  5. 5.0 5.1 Paravati AJ, Mell LK, et al. "Variation in the Cost of Radiation Therapy Among Medicare Patients with Cancer." J Oncol Pract. 2015;11(5):403-409. https://pmc.ncbi.nlm.nih.gov/articles/PMC4575405/
  6. 6.0 6.1 Zafar SY. "Financial toxicity of cancer care: it's time to intervene." J Natl Cancer Inst. 2016;108(5):djv370. https://pmc.ncbi.nlm.nih.gov/articles/PMC5985271/
  7. 7.0 7.1 7.2 Centers for Medicare & Medicaid Services. Medicare Part D out-of-pocket cap under the Inflation Reduction Act. https://www.cms.gov/inflation-reduction-act-and-medicare
  8. 8.0 8.1 8.2 Taioli E, Wolf AS, et al. "Patterns of Care and Survival Among Patients with Malignant Mesothelioma in the United States." Lung Cancer. 2018;115:55-60. https://pmc.ncbi.nlm.nih.gov/articles/PMC5726440/
  9. Blaj S, Giglia M, et al. "Evaluation of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a community setting." J Surg Oncol. 2016;113(4):461-466. https://pubmed.ncbi.nlm.nih.gov/26750613/
  10. American Cancer Society. "CAR T-cell Therapy and Its Side Effects." https://www.cancer.org/cancer/managing-cancer/treatment-types/immunotherapy/car-t-cell.html
  11. Mesothelioma Treatment Options, Mesothelioma.net.
  12. Kaiser Family Foundation. "2024 Employer Health Benefits Survey." https://www.kff.org/health-costs/report/2024-employer-health-benefits-survey/
  13. Medicare.gov. "Medicare and Hospice Benefits: Getting Started." https://www.medicare.gov/publications/11361-medicare-hospice-getting-started.pdf
  14. Danziger & De Llano, LLP, Mesothelioma Attorneys.
  15. Mesothelioma Treatment, Mesothelioma Lawyer Center.
  16. Yoon J, Chee CP, et al. "Working, Low Income, and Cancer Caregiving: Financial and Mental Health Impacts." JCO Oncol Pract. 2023;19(8):e1249-e1260. https://pmc.ncbi.nlm.nih.gov/articles/PMC10414725/

Cite error: <ref> tag with name "nci_ft" defined in <references> is not used in prior text.


This quick reference page is maintained by WikiMesothelioma.com and updated as treatment costs change. Last reviewed: March 2026.